Inotiv, Inc. (NOTVQ) vs T2 Biosystems, Inc. (TTOO)
Inotiv, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $2.8M — 2.3× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −30.2%. Inotiv, Inc. has the higher net margin (−17.1% vs −559.5%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 16 metrics below, T2 Biosystems, Inc. leads on 9 and Inotiv, Inc. on 7.
Valuation
Profitability
| Metric | NOTVQ | TTOO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 22.94% | (76.76%) | 50.89% |
| Operating margin | (9.48%) | (542.59%) | (8.57%) |
| Net margin | (17.14%) | (559.52%) | (6.37%) |
| Free cash flow margin | (1.95%) | (476.64%) | 0.00% |
| Return on equity | (74.09%) | 277.61% | (2.92%) |
| Return on assets | (11.85%) | (140.00%) | (6.71%) |
| Return on invested capital | (6.19%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack